The Asia Pacific Pediatric Association (APPA) position statement on the MAFLD definition of fatty liver disease.

IF 3.3 3区医学 Q2 PHARMACOLOGY & PHARMACY

Therapeutic Advances in Chronic Disease Pub Date : 2023-01-01 DOI:10.1177/20406223231164523

Iqbal A Memon, Arit Parkash, Kamran Sadiq, Naglaa M Kamal, Mortada H F El-Shabrawi

引用次数: 0

Abstract Image

查看原文本刊更多论文

亚太儿科协会(APPA)关于脂肪肝疾病MAFLD定义的立场声明。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutic Advances in Chronic Disease Medicine-Medicine (miscellaneous)

CiteScore

6.20

自引率

0.00%

发文量

108

审稿时长

12 weeks

期刊介绍： Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area.